Seismic Therapeutic, Inc., the machine learning immunology company, today announced the dosing of the first healthy subject ...
Myrobalan to receive over $850,000 in funding to advance the development of its GPR17 antagonist for progressive MS from the ...
YEN.com.gh on MSN2d
Drogba: YOLO actor John Peasah shows sign of recovery from his health issues, hangs out with co-starGhanaian actor John Peasah showed signs of recovery from his health issues as he hung out with his co-star Stephanie Younge ...
Phase 2 MaGic trial of DNTH103 in generalized Myasthenia Gravis (gMG) ongoing; top-line results on track for 2H’25Phase 3 CAPTIVATE trial of ...
Dublin, March 05, 2025 (GLOBE NEWSWIRE) -- The "Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) - Pipeline Insight, 2025" report has been added to ResearchAndMarkets.com's offering. A recent ...
Treatments for autoimmune diseases and those in orphan markets are on the up and up, as are drugmakers’ first launches, ...
New research highlights a critical link between antibodies produced against Epstein-Barr virus (EBV) and the development of ...
The Brighterside of News on MSN7h
Breakthrough new drug can restore human vision loss, study findsMyelin, the protective sheath around nerve fibers, plays a crucial role in brain communication. It ensures fast and efficient ...
Guggenheim reiterated their buy rating on shares of Immunovant (NASDAQ:IMVT – Free Report) in a report issued on Monday ...
Pune continues to be plagued by Guillain-Barré Syndrome worries, after the 12th suspected GBS death was recorded in Pune ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback